123121P.pdf   01/09/2014  Christine Winter  v.  Novartis Pharmaceuticals Corp.
   U.S. Court of Appeals Case No:  12-3121
                          and No:  12-3409
   U.S. District Court for the Western District of Missouri - Jefferson City   
   [PUBLISHED] [Benton, Author, with Loken and Colloton, Circuit Judges] 
   Civil case - Products Liability. Evidence was sufficient to support the 
   jury's verdict that plaintiff's injuries were the natural and probable 
   consequence of defendant's negligent failure to provide adequate warnings 
   for its two drugs, Aredia and Zometa; the district court did not err in 
   applying Missouri's punitive damages law, as Missouri had the most 
   significant relationship to the claim; any error in the admission of 
   information from the FDA's adverse event reporting program was harmless as 
   the forms admitted were cumulative of other evidence that defendant knew 
   of certain risks associated with the drugs; where litigation costs are 
   incurred in connection with more than one proceeding, the court should 
   allocate the costs, and the the court abused its discretion in awarding 
   the entire amount of these costs in plaintiff's case.